MIHOKO FUJITA, MD
Radiation Oncology Physician in WASHINGTON, District of Columbia. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What stands out: MIHOKO FUJITA, MD reported a CMS MIPS final score of 79.2264 out of 100, below the 83.1 national average, and filed 47 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.
MIHOKO FUJITA, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
MIHOKO FUJITA, MD at a glance
Near national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in District of Columbia
How Radiation Oncology Physician compares to other specialties among District of Columbia providers
Radiation Oncology Physician share within District of Columbia
Radiation Oncology Physician is one of the more visible NUCC categories in District of Columbia
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
MIHOKO FUJITA, MD's 2023 MIPS final score plotted against the Radiation Oncology Physician national average
- MIPS Final Score
- 79.2264/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Radiation Oncology Physician) — 79.2264/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Radiation Oncology Physician US NPIs
79.2264/100 MIPS final score — 3.9 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Radiation Oncology Physician. Quality dim: 86.143. Cost dim: 47.1116.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
MIHOKO FUJITA, MD is a Radiation Oncology Physician provider practicing in WASHINGTON, District of Columbia, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1447295746. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.
MIHOKO FUJITA, MD appears in the CMS NPPES registry as a Radiation Oncology Physician provider holding MD credentials at 2041 GEORGIA AVE NW, WASHINGTON, DC, 20060, with a listed phone of (202) 865-1421. NPI 1447295746 was issued on 06/19/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what FUJITA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 47 prescription claims written by this provider, covering 25 Medicare beneficiaries and totaling roughly $1K in drug spend. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 79.2264/100 for the 2023 performance year (Quality 86.143, Cost 47.1116), compared with the national average of 83.1.
Radiation Oncology Physician is a mid-sized specialty nationwide, with 6,018 enrolled providers across 52 states and an average of 186 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1447295746 |
|---|---|
| Specialty | Radiation Oncology Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 06/19/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm MIHOKO FUJITA, MD's current license status, disciplinary history, and board certifications with the D.C. Board of Medicine in District of Columbia before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where MIHOKO FUJITA, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 51
- Total Day Supply
- 1,251
- Generic Drug Cost
- $1K
Patient Demographics
- Average Patient Age
- 73.1 years
- Avg HCC Risk Score
- 1.74
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
| Drug | Claims |
|---|---|
| Tamsulosin Hcl | 18 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Radiation Oncology Physician Overview
How MIHOKO FUJITA, MD fits within the Radiation Oncology Physician landscape nationally.
MIHOKO FUJITA, MD's 47 claims are below the specialty average of 186.
Nearby Radiation Oncology Physician Providers in District of Columbia
Other clinicians with the same primary specialty enrolled in District of Columbia, drawn from the same CMS NPPES roster as FUJITA.
Compare Radiation Oncology Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore District of Columbia
Frequently Asked Questions
What is MIHOKO FUJITA, MD's specialty? ▼
How much does MIHOKO FUJITA, MD prescribe under Medicare Part D? ▼
What is MIHOKO FUJITA, MD's Medicare quality score? ▼
Where is MIHOKO FUJITA, MD located? ▼
What is MIHOKO FUJITA, MD's NPI number? ▼
How many Radiation Oncology Physician providers are there in the US? ▼
What drugs does MIHOKO FUJITA, MD prescribe most often? ▼
Does MIHOKO FUJITA, MD accept Medicare? ▼
How can I verify MIHOKO FUJITA, MD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology